Patents by Inventor Shiqun WANG

Shiqun WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10821104
    Abstract: A five-membered heterocyclic amide WNT pathway inhibitor having the following general structural formula: The five-membered heterocyclic amide WNT pathway inhibitor has a remarkable anti-tumor activity based on a target-based rational drug design, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: November 3, 2020
    Assignee: Suzhou Sinovent Pharmaceuticals Co., Ltd.
    Inventors: Yonghui Wang, Yan Zhu, Juan Zhou, Yujun Gao, Shiqun Wang, Dong Wang, Wandeng Liu, Ximing Shen, Binbin Hong, Tao Liu, Yaodong Wu, Chunqi Li
  • Publication number: 20180271846
    Abstract: The present invention discloses a five-membered heterocyclic amide WNT pathway inhibitor, which belongs to a compound that regulates the activity of a Wnt signaling pathway, and provides a method for preparing such a compound, and the use of such a compound in preparing a medicament that antagonizes the Wnt signaling pathway. The five-membered heterocyclic amide WNT pathway inhibitor provided by the invention has a remarkable anti-tumor activity based on a target-based rational drug design of, and can be used for the development of a new generation of Wnt pathway inhibitors, and has a great clinical application value and considerable market potential.
    Type: Application
    Filed: December 7, 2016
    Publication date: September 27, 2018
    Inventors: Yonghui WANG, Yan ZHU, Juan ZHOU, Yujun GAO, Shiqun WANG, Dong WANG, Wandeng LIU, Ximing SHEN, Binbin HONG, Tao LIU, Yaodong WU, Chunqi LI